A multilocus phylogenetic study was carried out to assess species identity of a set of 34 clinical isolates from Aspergillus section Circumdati from the United States and to determine their in vitro antifungal susceptibility against eight antifungal drugs. The genetic markers used were the internal transcribed spacer (ITS) region, and fragments of the beta-tubulin (BenA), calmodulin (CaM), and RNA polymerase II second largest subunit (RPB2) genes. The drugs tested were amphotericin B, itraconazole, posaconazole, voriconazole, anidulafungin, caspofungin, micafungin, and terbinafine. The most common species sampled was A. westerdijkiae (29.4%), followed by a novel species, which was described here as A. pseudosclerotiorum (23.5%). Other species identified were A. sclerotiorum (17.6%), A. ochraceus (8.8%), A. subramanianii (8.8%), and A. insulicola and A. ochraceopetaliformis, with two isolates (5.9%) of each. The drugs that showed the most potent activity were caspofungin, micafungin, and terbinafine, while amphotericin B showed the least activity.KEYWORDS Aspergillus, Circumdati section, clinical isolates, molecular identification, phenotypic identification S ection Circumdati includes aspergilli with biseriate conidial heads in shades of yellow to ochre, with mostly globose vesicles, and sclerotia variable in shape and color (1-3). It contains 26 species (3), with A. ochraceus being the best known and described as an important producer of many extrolites, including the mycotoxin ochratoxin A (3-5). This metabolite has nephrotoxic, immunosuppressive, teratogenic, and carcinogenic properties (6, 7) and is commonly found in coffee, rice, beverages, and other contaminated foodstuffs (3,8). Several species in this section have been involved in different types of infections, such as onychomycosis, caused by A. insulicola, A. melleus, A. ochraceopetaliformis, A. persii, A. sclerotiorum, and A. westerdijkiae (9-14); otomycosis, caused by A. sclerotiorum (15); skin infection, caused by A. westerdijkiae (12); and pulmonary aspergillosis and osteomyelitis, caused by A. ochraceus (16,17). Moreover, A. ochraceus, A. sclerotiorum, and A. westerdijkiae have been repetitively isolated from clinical specimens of immunocompromised patients, although in such cases their pathogenic role is uncertain (18)(19)(20)(21)(22).There are few data on the in vitro antifungal susceptibility of species within section Circumdati. The azoles, especially itraconazole, appear to have good activity against A.